pentosidine has been researched along with MS (Multiple Sclerosis) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chadha, K; George, R; Hojnacki, D; Johnson, J; Kolb, C; Nir, A; Nir, R; Sternberg, Z; Yu, J | 1 |
| Braun, M; Germanová, A; Havrdová, E; Kalousová, M; Mrázová, K; Spacek, P; Uhrová, J; Zima, T | 1 |
2 other study(ies) available for pentosidine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients.
Topics: Adult; Anti-Inflammatory Agents; Antigens, Neoplasm; Arginine; Female; Fingolimod Hydrochloride; HMGB1 Protein; Humans; Lysine; Male; Middle Aged; Mitogen-Activated Protein Kinases; Multiple Sclerosis; Neuroprotective Agents; Receptor for Advanced Glycation End Products; Young Adult | 2018 |
Advanced glycoxidation end products in patients with multiple sclerosis.
Topics: Adult; Arginine; Cerebrospinal Fluid Proteins; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Multiple Sclerosis; Myelin Basic Protein; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2005 |